View stunning SlideShares in full-screen with the new iOS app!Introducing SlideShare for AndroidExplore all your favorite topics in the SlideShare appGet the SlideShare app to Save for Later — even offline
View stunning SlideShares in full-screen with the new Android app!View stunning SlideShares in full-screen with the new iOS app!
Every IRG is being assessed by all senior CSR staff every 2 years in addition to the current 5-year assessments involving all stakeholders.
Emergent problems addressed by working groups with leaders from the extramural community, and senior NIH/CSR staff.
Substantive issues/changes reviewed by the NIH Peer Review Advisory Committee.
Most study sections visited by CSR’s Director and senior staff at least once a year.
All retiring study section chairs called by CSR’s Director to learn about problems and possible improvements.
All summary statements read by CSR’s Director.
Multiple outreach efforts now gather fresh input.
IRG Review Schedule Renal and Urological Sciences (RUS) Respiratory Sciences (RES) Surgical Sciences, Biomedical Imaging and Bioengineering (SBIB) Oncological Sciences (ONC) Musculoskeletal, Oral and Skin Sciences (MOSS) Cell Biology (CB) Biobehavioral and Behavioral Processes (BBBP) Infectious Diseases and Microbiology (IDM) Biology of Development and Aging (BDA) Scheduled 2007 -- 9 IRGs Health of the Population (HOP) Immunology (IMM) Hematology (HEME) Molecular, Cellular and Developmental Neuroscience (MDCN) Integrative, Functional and Cognitive Neuroscience (IFCN) Brain Disorders and Clinical Neuroscience (BDCN) Endocrinology, Metabolism, Nutrition and Reproductive Sciences (EMNR) Digestive Sciences (DIG) Genes, Genomes and Genetics (GGG) Risk, Prevention, and Health Behavior (RPHB) AIDS and Related Research (AARR) Bioengineering Sciences and Technologies (BST) Cardiovascular Science (CVS) Biological Chemistry and Macromolecular Biophysics (BCMB) Scheduled 2006 --14 IRGs
Will increase number of applications reviewed by reviewers
Will decrease the number of reviewers in a study section
May be combined with a change in format of the application, more consonant to review criteria
Strong support by councils and scientific leadership
May result in better focus on significance (and innovation)
Trans-NIH Committee to Shorten the Application Chairs Robert Finkelstein, Ph.D. (Co-Chair), NINDS Donald Schneider, Ph.D. (Co-Chair), CSR Members Mary Custer, Ph.D. CSR Ann A. Hagan, Ph.D. NIGMS Craig A. Jordan, Ph.D. NIDCD Sherry Mills, M.D., M.P.H. OER Philip F. Smith, Ph.D. NIDDK Barbara Spalholz NCI Betsy Wilder, Ph.D. NIDDK Alan L. Willard, Ph.D. NINDS